Role of antiplatelet therapy in the development of intracranial bleeding after mild traumatic brain injury

The use of antiplatelet agents is increasing, mainly in elderly patients in whom cranial trauma is a frequent reason for consultation to the emergency department. In this context, discordances have been described regarding the increased risk of post-traumatic injury that involves taking antiplatelet...

Full description

Saved in:
Bibliographic Details
Published in:Medicina clínica (English ed.) 2020-01, Vol.154 (2), p.52-54
Main Authors: Genebat González, Miguel, Dusseck Brutus, Reginald, García-Olloqui, Ángel, García-Delgado Rosado, Horacio, Bellido Alba, Rafael, Pérez Torres, Ignacio
Format: Article
Language:English
Subjects:
Antiplatelet therapy
Brain injury
Intracranial bleeding
Sangrado intracraneal
Terapia antiagregante
Traumatismo craneal
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of antiplatelet agents is increasing, mainly in elderly patients in whom cranial trauma is a frequent reason for consultation to the emergency department. In this context, discordances have been described regarding the increased risk of post-traumatic injury that involves taking antiplatelet drugs. Therefore, the objective of this present study was to analyse factors associated with intracranial bleeding after mild brain trauma. A retrospective study was designed that included all patients who had consulted the emergency department during 2016 because of mild brain trauma (Glasgow coma scale 14–15) and excluded patients under anticoagulant therapy. A logistic regression analysis was performed to analyse the variables associated with intracranial bleeding. 566 patients were included in the study. 18% of them were taking antiplatelet drugs. Tomography showed haemorrhagic intracranial damage in 16.1%. Factors associated with intracranial bleeding were: advanced age, Glasgow coma scale
ISSN:2387-0206
2387-0206
DOI:10.1016/j.medcle.2019.01.046